Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials
about
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionPrimaquine for reducing Plasmodium falciparum transmissionTafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to dateReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportGlucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort StudyGlucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina FasoGlucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, MaliMolecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - IraqAssociations between red cell polymorphisms and Plasmodium falciparum infection in the middle belt of GhanaEvaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand.Thrombophilic gene polymorphism studies in G6PD deficient individuals from Saudi population.Analysis of G6PD enzyme deficiency in Saudi population.Insertion/Deletion polymorphisms do play any role in G6PD deficiency individuals in the Kingdom of the Saudi Arabia.Biomarkers for the differentiation of anemia and their clinical usefulness.Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in TanzaniaGlucose-6-phosphate dehydrogenase deficiency among children attending the Emergency Paediatric Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto, NigeriaMolecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish.Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana.PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.[Frequency of glucose-6-phosphate dehydrogenase deficiency (A-376/202) in three Malian ethnic groups].Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.Influence of coadministration of artemether and lumefantrine on selected plasma biochemical and erythrocyte oxidative stress indices in female Wistar rats.Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome.Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approachesAssociations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control studyGlucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study
P2860
Q24188070-584FA74B-6CE9-4E44-8363-0717D95DB886Q24193716-B95617F7-BF0C-4337-99EF-32DBF27EEF38Q24200471-2332C235-86E9-4DCF-A70A-D1D0A8F1D912Q26741307-C04D76E5-CAFF-4B73-AFBA-9F3BC27FE5E5Q27024922-365A9B93-6904-4AF6-9C1C-9E5FA8E0AFFEQ28547654-0211EE2F-8E0A-4571-AB49-0E259CA4D6D8Q33682046-C309F951-5337-49B0-9701-E12D4AA29188Q33948158-B4309F6B-DFA5-40E8-89F5-FF83479B8D8FQ34209338-7C9FC9EA-489A-44A1-A409-704E49A6AE82Q34623911-17123F8D-1EE7-4941-8689-ECA61392022FQ35464096-9CE7DD99-8FE3-4DEB-A720-38104D2AC880Q35542748-EBF73769-2250-407D-9462-CDEC5901819EQ35564214-680635AE-9BC4-4267-8ABD-0D23B88FFDD9Q35777347-C47C8ABA-EA13-471B-BF26-C70640EF6923Q36493530-2A9FBF58-035B-4B71-9720-134163DC39B0Q36493534-C0A9205D-BDAC-47F8-8717-3CD18AAD5411Q36584972-D05B02C7-E0C0-4070-878F-4D3BC478B966Q36723424-B22C8DD0-78B6-418A-8F1B-822C297C3AAAQ36991071-6DAD3BA8-4E8B-4A2D-BF14-9DC95016D490Q37014069-1F5DACC4-FB18-45ED-8282-ACA2EC335C62Q37055399-2449EA5C-064B-43EB-AE4B-8D59D3BF28C3Q37077031-035FA72D-71ED-4DF3-AA5E-94493BBE333EQ37125793-72ECF485-D100-4FF3-B385-91D7961917BFQ37377766-0A15AD45-5925-4507-94D2-76617BE65AC1Q37491136-3B3D6A33-4BDC-46E0-9FA4-79B4561FC3B7Q37581776-2693AA8C-408D-4BAB-8FEA-CD118090CD19Q38849331-C5213F46-B5AE-4451-B238-4F8FA6C44C98Q38921632-1E76B9B7-60CA-404A-BA65-57C50E232862Q39288052-D3B5355D-F447-4D6E-B24E-05EF095CBF99Q42363951-679DAC0D-0836-4D86-B503-A08EC62F029DQ43923789-754416E5-0531-4320-8AB6-12A8990F1F96Q47872390-B2BABEE4-9198-436A-93B6-E455E619CF82Q48024114-6796A57D-8816-4C67-A103-AD892F48E8BAQ50586789-9D3CB0E7-3750-476B-A179-FE99C2E4588CQ51762424-7B6CB556-DB90-44D3-A1ED-8A0E0683EBF9Q52348869-D4975F01-FCFD-44AC-A99F-316C949B77AAQ54571723-47982743-D412-4865-A315-B90B185590C0Q56348671-C666209C-3380-48D0-BF0B-7488D41B170EQ56909428-026A6BC4-A542-40DA-A1FE-7AD24CDAD830Q58115299-508EA5C7-C8BD-41F4-B112-915E40ADB542
P2860
Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@ast
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@en
type
label
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@ast
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@en
prefLabel
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@ast
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@en
P2093
P2860
P356
P1433
P1476
Frequency of glucose-6-phospha ...... anti-malarial clinical trials
@en
P2093
Allan Pamba
John N Waitumbi
Nick Carter
Stephan Duparc
P2860
P2888
P356
10.1186/1475-2875-10-241
P577
2011-08-17T00:00:00Z
P5875
P6179
1023952412